Session Details

[O-12]Oral Session 12 Neuroimmunology 2 (GBS)

Thu. May 22, 2025 9:45 AM - 10:45 AM JST
Thu. May 22, 2025 12:45 AM - 1:45 AM UTC
第02会場(大阪国際会議場5F 小ホール)
Chair: Kenichi Kaida(Dept. of Neurology, Saitama Medical Center, Saitama Medical University, Japan)

[O-12-1]Validity of EAN/PNS diagnostic criteria in patients with Guillain-Barré syndrome

Miki Fukazawa, Toshiyuki Hayashi, Seira Sakurai, Hiroshi Nagayama, Kazumi Kimura (Department of Neurology, Nippon Medical School Hospital, Japan)

[O-12-2]Clinical characteristics of GBS with cranial nerve involvements-Japanese prospective study

Yuko Yamagishi1, Motoi Kuwahara1, Makoto Samukawa1, Susumu Kusunoki1,2, Yoshitaka Nagai1, Japanese GBS outcome study group2 (1.Department of Neurology, Kindai University Faculty of Medicine, Japan, 2.Japanese GBS outcome study group, Japan)

[O-12-3]Anti-Ganglioside Antibodies and Clinical Features in COVID-19-Associated Guillain-Barré Syndrome

Mitsuhiro Kainaga, Ayumi Uchibori, Yaeko Ichikawa (Department of Neurology, Kyorin University School of Medicine, Japan)

[O-12-4]Sites of conduction blocks in acute motor axonal neuropathy

Teruhiko Sekiguchi1, Yuta Sanjo1, Kazuma Yokota1, Naoki Yonezawa2, Motoi Kuwahara3, Takuya Ohkubo1 (1.Department of Neurology, Yokohama City Minato Red Cross Hospital, Japan, 2.Department of Emergency and Critical Care Medicine, Yokohama City Minato Red Cross Hospital, Japan, 3.Department of Neurology, Kindai University, Faculty of Medicine, Japan)